No Result
View All Result
SUBSCRIBE | NO FEES, NO PAYWALLS
MANAGE MY SUBSCRIPTION
NEWSLETTER
Corporate Compliance Insights
  • Home
  • About
    • About CCI
    • CCI Magazine
    • Writing for CCI
    • Career Connection
    • NEW: CCI Press – Book Publishing
    • Advertise With Us
  • Explore Topics
    • See All Articles
    • Compliance
    • Ethics
    • Risk
    • FCPA
    • Governance
    • Fraud
    • Internal Audit
    • HR Compliance
    • Cybersecurity
    • Data Privacy
    • Financial Services
    • Well-Being at Work
    • Leadership and Career
    • Opinion
  • Vendor News
  • Library
    • Download Whitepapers & Reports
    • Download eBooks
    • New: Living Your Best Compliance Life by Mary Shirley
    • New: Ethics and Compliance for Humans by Adam Balfour
    • 2021: Raise Your Game, Not Your Voice by Lentini-Walker & Tschida
    • CCI Press & Compliance Bookshelf
  • Podcasts
    • Great Women in Compliance
    • Unless: The Podcast (Hemma Lomax)
  • Research
  • Webinars
  • Events
  • Subscribe
Jump to a Section
  • At the Office
    • Ethics
    • HR Compliance
    • Leadership & Career
    • Well-Being at Work
  • Compliance & Risk
    • Compliance
    • FCPA
    • Fraud
    • Risk
  • Finserv & Audit
    • Financial Services
    • Internal Audit
  • Governance
    • ESG
    • Getting Governance Right
  • Infosec
    • Cybersecurity
    • Data Privacy
  • Opinion
    • Adam Balfour
    • Jim DeLoach
    • Mary Shirley
    • Yan Tougas
No Result
View All Result
Corporate Compliance Insights
Home Compliance

Big Data Anomalies Can’t Be Used to Prosecute. But Identifying Them Can Help Avoid Potential Lawsuits or Enforcements.

Robust Data Analytics Can Identify Anomalies Before Competitors Use Them Against You.

by Jessica Ellsworth
July 13, 2021
in Compliance
An abstract blue background comprised of squares, representing data.

In a recent Ninth Circuit Court of Appeals case, prosecutors tried to stake their argument on their analysis of anomalies in big datasets. It didn’t work. The proceedings nevertheless highlight how useful data analytics can be in the compliance function.

Plaintiffs and government enforcement agencies increasingly rely on data analysis to support a wide array of allegations, including employment discrimination, insider trading, bid rigging, False Claims Act (FCA) violations and more. Although a recent Ninth Circuit decision in Integra Med Analytics LLC v. Providence Health & Services[1] reminds litigants that statistical anomalies alone are not sufficient to state a claim for fraud, enforcement authorities and civil litigants nonetheless increasingly employ data analytics to build their cases. Compliance-oriented companies should therefore harness their own sources of data to enhance their compliance programs, to identify events worthy of compliance investigations and to ultimately develop an understanding of significant statistical anomalies before prosecutors, qui tam relators or class-action lawyers come knocking.

Lessons from Providence Health

In Providence Health, a qui tam relator filed an FCA claim on behalf of the United States alleging that Providence Health & Services, its affiliated hospitals (Providence) and J.A. Thomas & Associates, Inc. (JATA) filed false claims for government reimbursement under the Medicare program. The relator, Integra Med Analytics, LLC, a data-analytics company, alleged that Providence submitted Medicare claims that were coded for more lucrative secondary diagnoses and that were not supported by patients’ conditions. This claim was based primarily on Integra’s “proprietary statistical analysis” of data received from the Centers for Medicare and Medicaid Services (CMS).[2] The relator claimed its analysis demonstrated that Providence submitted claims that included a higher rate of coding for these secondary diagnoses than other comparable institutions, that it controlled for inter-hospital variation caused by different characteristics in patient populations and that “there was less than a one-thousandth percent chance” that Providence’s greater rate of coding of these conditions was “due to chance.”[3]

The defendants moved to dismiss, and the district court granted their motions in part and denied them in part, allowing Integra’s primary FCA claim to proceed. At the defendants’ request, the district court certified its order for interlocutory appeal. On appeal, the Ninth Circuit concluded Integra had not adequately pleaded the falsity of Providence’s Medicare claims. The court explained that in order to survive a motion to dismiss, a claim must be plausible. And, in evaluating plausibility, courts must consider an “obvious alternative explanation” for the defendant’s behavior.[4] Here, the court found Integra’s allegations “do not eliminate an obvious alternative explanation — that Providence, with JATA’s assistance, was more effective at properly coding for better Medicare reimbursement than others in the health care industry.”[5]

The court accepted Integra’s allegations that:

  1. Providence used the secondary codes at a higher rate than other comparable institutions,
  2. this difference was not due to chance or variations in patient populations and
  3. Providence and JATA staff incentivized doctors to use language conducive to coding higher-paying secondary diagnoses through their documentation tips and queries.

But still it reasoned that it “need not — and cannot — accept the conclusion that these allegations resulted from fraud or that doctors recorded unsupported medical conditions.”[6] Therefore, the Ninth Circuit concluded Integra had not stated a plausible claim for relief and reversed the district court’s order denying the defendants’ motions to dismiss.

The Government’s Increasing Reliance on Data Analytics

The Providence Health decision offers some limitation on the ability of plaintiffs and the government to rely solely on data and statistics to sustain claims for relief, and more specifically, fraud or false claims. However, it does not eliminate the important role that data analytics now plays in shaping government enforcement and private litigation. Even the Providence Health court acknowledges that its decision “does not categorically preclude statistical data from being used to meet Rule 8(a)’s pleading requirement and, when paired with particular details of a false claim, Rule 9(b).”[7]

In 2019, then Deputy Assistant Attorney General Matthew S. Miner explained in a speech delivered to the Government Enforcement Institute that prosecutors were increasingly relying on data analytics to more efficiently identify targets for investigations. He specifically mentioned enforcement actions relating to Medicare claims and to securities and commodities trading. In addition, the DOJ’s Procurement Collusion Strike Force has reported that it is working to bolster the capabilities of data teams across the government to detect bid rigging and other crimes.

Deputy Assistant Attorney General Miner’s remarks explained that not only should companies expect that enforcement teams may rely on publicly available data to identify indicators of anomalies that warrant investigation, they should also expect that if misconduct does occur, “prosecutors are going to inquire about what the company has done to analyze or track its own data resources.”[8] This suggestion was subsequently incorporated into the DOJ’s June 2020 revised guidance for DOJ prosecutors evaluating whether a corporate compliance program was effective at the time of an offense and is effective at the time of a charging decision or resolution. This revised guidance now instructs that while evaluating whether a corporation’s compliance program is adequately resourced and empowered to function effectively, prosecutors should examine the following questions:

  1. “Do compliance and control personnel have sufficient direct or indirect access to relevant sources of data to allow for timely and effective monitoring and/or testing of policies, controls and transactions?” and
  2. “Do any impediments exist that limit access to relevant sources of data and, if so, what is the company doing to address the impediments?”

Looking Ahead

Compliance professionals should take some comfort from the Ninth Circuit’s reminder that a statistical anomaly alone is not sufficient to state a claim where there is an obvious alternative explanation. However, the Providence Health decision also serves as a reminder that private plaintiffs, as well as enforcement agencies, are increasingly relying on data analysis to identify potential claims or targets for investigations. Companies should, therefore, use the data they have at their disposal to improve their own compliance efforts. Such efforts might include:

  • Employing data analytics to identify anomalies in sales data, customer complaints, payments to consultants or other third parties, reimbursements to employees and other data sources. Compliance professionals should identify the major risk areas for their company and industry and then work with other departments to identify potentially useful sources of data.
  • Data analytics can also be used to create dynamic tools that can illustrate patterns over time (i.e., sales by country or reimbursements to third parties), which can help identify new compliance risks as they emerge. For example:
    • Sales data can be monitored in real time to ensure unusually large increases in sales to particular customers are monitored.
    • Travel data can also be examined to help the compliance department identify activities in new jurisdictions that might raise new compliance issues.

Data analytics should, of course, supplement, not replace, traditional compliance functions. Harnessing data can help target the work of compliance teams, thus enabling compliance professionals to spend more of their time on complex issues like determining the real causes of statistical anomalies that data analytics may surface. As the Providence Health decision underscores, examining and understanding the causes of such anomalies may prove important in future litigation.


[1] No. 19-56367, 2021 WL 1233378 (9th Cir. Mar. 31, 2021).

[2] Id. at *2.

[3] Id. See also id. at n.3 (noting that Integra’s complaint also states that Integra “only considered claim groupings where there was less than a one-in-a-thousand chance that the difference in major complication rate at Providence versus other hospitals was due to random causes”).

[4] Id. at *3 (citing Eclectic Props. E., LLC v. Marcus & Millichap Co., 751 F.3d 990, 996 (9th Cir. 2014), which was quoting Ashcroft v. Iqbal, 556 U.S. 662, 683 (2009)).

[5] Id. at *4.

[6] Id. at *3-4.

[7] Id. at *4 n.5.

[8] Miner, supra n.8.


Tags: Big DataData AnalyticsFalse Claims Act (FCA)
Previous Post

How the Pandemic Redefined General Counsel (GC)

Next Post

After COVID-19, It’s Not a Question of ‘If’ Another Disruption Will Occur. It’s ‘When.’

Jessica Ellsworth

Jessica Ellsworth

Jessica Ellsworth is a partner at Hogan Lovells in the firm’s Litigation, Arbitration and Employment practice group, specifically focusing on False Claims Act cases, Appellate and Supreme Court litigation. She is located in Washington DC.

Related Posts

abstract obscured data colorful

NIST’s Differential Privacy Guidelines: 6 Critical Areas for Secure Implementation

by Michelle Drolet
June 16, 2025

Standard de-identification methods remain vulnerable to sophisticated attacks, but differential privacy offers mathematical guarantees that scale with emerging threats

check engine light

What Gets Measured Gets Managed, but What Actually Matters in Compliance?

by Keshonda Walker
May 16, 2025

Looking beyond standard measurements to identify the quiet signals that help compliance teams address issues before they become crises

hidden value abstract

CCO Insights: How to Articulate the True Value of Your Compliance Program

by Kenneth Koch and Phillip Ostwalt
May 14, 2025

Benefits of robust programs aren’t always obvious, but buy-in remains critical

pinocchio doll lying long nose

Trump’s DOJ & the False Claims Act: What’s Next?

by Maria Durant and Gejaa Gobena
April 1, 2025

The False Claims Act continues to be a powerful enforcement tool, with nearly $3 billion recovered in 2024 alone. Maria...

Next Post
A discarded face mask lies on the ground.

After COVID-19, It's Not a Question of 'If' Another Disruption Will Occur. It's 'When.'

No Result
View All Result

Privacy Policy | AI Policy

Founded in 2010, CCI is the web’s premier global independent news source for compliance, ethics, risk and information security. 

Got a news tip? Get in touch. Want a weekly round-up in your inbox? Sign up for free. No subscription fees, no paywalls. 

Follow Us

Browse Topics:

  • CCI Press
  • Compliance
  • Compliance Podcasts
  • Cybersecurity
  • Data Privacy
  • eBooks Published by CCI
  • Ethics
  • FCPA
  • Featured
  • Financial Services
  • Fraud
  • Governance
  • GRC Vendor News
  • HR Compliance
  • Internal Audit
  • Leadership and Career
  • On Demand Webinars
  • Opinion
  • Research
  • Resource Library
  • Risk
  • Uncategorized
  • Videos
  • Webinars
  • Well-Being
  • Whitepapers

© 2025 Corporate Compliance Insights

Welcome to CCI. This site uses cookies. Please click OK to accept. Privacy Policy
Cookie settingsACCEPT
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT
No Result
View All Result
  • Home
  • About
    • About CCI
    • CCI Magazine
    • Writing for CCI
    • Career Connection
    • NEW: CCI Press – Book Publishing
    • Advertise With Us
  • Explore Topics
    • See All Articles
    • Compliance
    • Ethics
    • Risk
    • FCPA
    • Governance
    • Fraud
    • Internal Audit
    • HR Compliance
    • Cybersecurity
    • Data Privacy
    • Financial Services
    • Well-Being at Work
    • Leadership and Career
    • Opinion
  • Vendor News
  • Library
    • Download Whitepapers & Reports
    • Download eBooks
    • New: Living Your Best Compliance Life by Mary Shirley
    • New: Ethics and Compliance for Humans by Adam Balfour
    • 2021: Raise Your Game, Not Your Voice by Lentini-Walker & Tschida
    • CCI Press & Compliance Bookshelf
  • Podcasts
    • Great Women in Compliance
    • Unless: The Podcast (Hemma Lomax)
  • Research
  • Webinars
  • Events
  • Subscribe

© 2025 Corporate Compliance Insights